首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD20 Recombinant Antibody(Ocrelizumab)

Anti-Human CD20 Recombinant Antibody(Ocrelizumab)

产品编号

YR1145

别名

科研级 Ocrelizumab ( 奥瑞组单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocrelizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Ocrelizumab ( 奥瑞组单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocrelizumab
Catalog NumberYR1145
Molecular NameOcrelizumab
CAS Number637334-45-3
Molecular Weight145 kDa
TargetCD20[Homo sapiens]
Antibody IsotypeIgG1
ClonityMonoclonal
Size1mg, 5mg
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundOcrelizumab, sold under the brand name Ocrevus, is a pharmaceutical drug for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug.
ApplicationELISA, IP, FCM, FuncS, Neut, IF
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价